Compare StocksABBV vs COST

AbbVie Inc. (ABBV) vs Costco Wholesale Corporation (COST): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. COST is overvalued at $952, with an intrinsic value of $452 and a margin of safety of -111%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
COST
Costco Wholesale Corporation
$951.89

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
COST
  • Costco Wholesale Corporation has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Costco Wholesale Corporation scores 96/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • Free cash flow has grown at a 30.8% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
COST
  • Gross margin of 12.9% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Despite buyback spending, shares outstanding increased in 3 out of 4 years — stock-based compensation is offsetting repurchases.
  • FCF yield of 1.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.

Key Valuation Metrics

Learn more →
ABBV
COST
Valuation
N/A
Free Cash Flow
$6.95B
N/A
FCF Yield
1.65%
70.89
Trailing P/E
47.86
15.41
Forward P/E
42.03
Quality & Moat
27.60%
ROIC
31.32%
N/A
ROE
29.15%
72.79%
Gross Margin
12.88%
0.41
PEG Ratio
4.62
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
-0.07
2.76%
Dividend Yield
0.62%
ABBV: 4Ties: 1COST: 3
ABBVCOST

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

COST

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
COST
$19.41
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$9.28B
Δ Market Cap
+$180.14B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
COST
110.8% Overvalued
Price is 110.8% above estimated fair value
Current Price: $951.89
Fair Value: $451.66
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

COST

What growth rate is the market pricing in at $952?

+20.8%
Market-Implied Owner Earnings Growth
Standard FCF implies +22.9%

The market implies +20.8% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +22.9%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
COST
96/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
COST
-2.65
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
COST
Insiders 0.2%Institutions 73.8%Retail & Other 26.0%
No. of Institutional Holders5,145
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
COST
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
0
Sells (12M)
No open market insider sales found.
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
COST
1
Sells (3M)
12
Sells (12M)
Total value (12M): $15.13M
DENMAN KENNETH D
Director
$847,345
@ $957.45 · 2026-06-23
FRATES CATON
Officer
$695,100
@ $993.00 · 2026-04-01
ADAMO CLAUDINE
Officer
$732,205
@ $1003.02 · 2026-03-09
JONES TERESA A
Officer
$838,318
@ $986.26 · 2026-01-21
DECKER SUSAN LYNNE
Director
$437,390
@ $955.00 · 2026-01-16
KLAUER JAMES C
Officer
$1.41M
@ $939.00 · 2026-01-14
POLIT JAVIER
Officer
$2.26M
@ $866.38 · 2025-12-30
WILCOX WILLIAM RICHARD
Officer
$2.23M
@ $930.13 · 2025-11-07
ADAMO CLAUDINE
Officer
$2.53M
@ $935.68 · 2025-10-24
BARBRE TIFFANY MARIE
Divisional Officer
$1.16M
@ $934.91 · 2025-10-24
FRATES CATON
Officer
$1.40M
@ $910.02 · 2025-09-29
JONES TERESA A
Officer
$595,230
@ $992.05 · 2025-08-20
RUBANENKO YORAM B.
Officer
$3.90M
@ $974.96 · 2025-07-14
DECKER SUSAN LYNNE
Director
$536,058
@ $980.00 · 2025-06-18
CALLANS PATRICK J
Officer
$3.01M
@ $1002.77 · 2025-06-09
RIEL PIERRE
Officer
$2.03M
@ $1014.15 · 2025-06-06
KLAUER JAMES C
Officer
$3.92M
@ $981.07 · 2025-04-17
MILLERCHIP GARY
Officer
$1.03M
@ $940.01 · 2025-03-27
ADAMO CLAUDINE
Officer
$830,304
@ $922.56 · 2025-03-24
FRATES CATON
Officer
$765,213
@ $900.25 · 2025-03-18
VACHRIS ROLAND MICHAEL
Chief Executive Officer
$3.35M
@ $931.00 · 2025-03-11
GALANTI RICHARD ALAN
Officer and Director
$1.27M
@ $894.97 · 2024-10-24
JONES TERESA A
Officer
$717,236
@ $896.54 · 2024-10-23
RIEL PIERRE
Officer
$1.79M
@ $896.71 · 2024-10-15
FRATES CATON
Officer
$1.50M
@ $883.35 · 2024-09-30
CALLANS PATRICK J
Officer
$2.23M
@ $893.94 · 2024-09-30
ADAMO CLAUDINE
Officer
$2.84M
@ $888.99 · 2024-09-30
DECKER SUSAN LYNNE
Director
$543,430
@ $876.50 · 2024-08-15
GALANTI RICHARD ALAN
Officer and Director
$868,962
@ $868.96 · 2024-08-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
COST
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
COST
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
View ABBV Full AnalysisView COST Full Analysis

Frequently Asked Questions: ABBV vs COST

Is AbbVie Inc. or Costco Wholesale Corporation more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -40.7% margin of safety (intrinsic value $178 vs. price $251), compared to COST's -110.8% margin of safety (intrinsic $452 vs. $952).

Which stock has a wider economic moat, AbbVie Inc. or Costco Wholesale Corporation?

COST scores 96/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. COST scores 9.2 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Costco Wholesale Corporation?

COST earns 31.3% ROIC versus ABBV's 27.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Costco Wholesale Corporation's?

COST's dividend earns a safety score of 85/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). COST has raised its dividend for 0 consecutive years.